Latest news with #RadhakishanDamani
News18
a day ago
- Business
- News18
Trent Shares Crash 11%: Radhakishan Damani Takes Rs 310 Crore Hit As Tata Stock Slumps
Ace Dalal Street investor Radhakishan Damani suffered a setback of over Rs 310 crore after shares of Trent Ltd tumbled 11%; Know why
Time of India
2 days ago
- Business
- Time of India
Radhakishan Shivkishan Damani portfolio: Ace investor's NSE stake hits Rs 9,300 crore ahead of IPO; exchange becomes his No. 2 holding by value after DMart
As the National Stock Exchange (NSE) moves closer to its long-awaited IPO, ace investor Radhakishan Damani 's early-stage investment in the bourse is delivering massive paper gains. His 1.58% stake—equivalent to 3.91 crore shares—is currently valued at around Rs 9,300 crore in the unlisted market, based on the latest grey market price of Rs 2,389 per share. This makes NSE Damani's second-largest holding by value, trailing only Avenue Supermarts ( DMart ), the retail major he founded, and placing it ahead of other notable portfolio bets such as Trent (Rs 2,788 crore) and VST Industries (Rs 1,560 crore). While it remains unclear whether Damani plans to offload any of his NSE shares during the IPO, the listing is poised to become a significant catalyst for his overall net worth, according to an ET report. The NSE stake stands out in a portfolio best known for high-conviction plays in consumer-facing sectors. Damani's core holding in DMart is currently valued at Rs 1.92 lakh crore. His investment in NSE reflects a broader strategic shift into financial infrastructure—low-noise, high-value assets with long-term tailwinds. As per data available for March 2025, Damani's portfolio across 12 publicly disclosed companies stands at over Rs 1.99 lakh crore. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo The NSE holding, now nearing Rs 10,000 crore in value, could add a powerful new dimension to that tally once the exchange is listed. The NSE IPO is expected to attract strong investor interest, given the exchange's dominant market share in cash equities, robust financials, and the resolution of key regulatory hurdles. The exchange received SEBI's green light to file its Draft Red Herring Prospectus (DRHP), with a potential listing likely by the final quarter of FY26. While legacy issues such as co-location and dark-fibre access had delayed NSE's IPO plans in the past, the resolution of these concerns has cleared the way for a formal listing process. Analysts expect strong demand for the issue, driven by the scarcity of listed plays in the financial infrastructure space. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
2 days ago
- Business
- Time of India
MobiKwik arm gets Sebi nod to operate as stock broker
One MobiKwik Systems broking arm, Mobikwik Securities Broking Private Limited (MSBPL), has received regulatory approval from the Securities and Exchange Board of India ( Sebi ) to act as a stockbroker/clearing member. One MobiKwik Systems wholly-owned subsidiary will now be able to carry on the activities of buying, selling, dealing, clearing and settlement of equity trades. In an exchange filing on Thursday, Mobikwik Securities said that it received Sebi's certificate of registration on Tuesday, July 1. The announcement positively triggered the stock price as One MobiKwik Systems shares jumped nearly 4% to hit the day's high of Rs 250.80 on the NSE. Aslo read: Rs 9,300 crore stake! NSE IPO to unlock massive value for billionaire Radhakishan Damani Live Events Since its inception, MobiKwik has transformed from a digital payments company into a diverse fintech platform. The company operates a consumer payments business with a network of over 17.64 crore users and 46 lakh merchants. The company filing claimed that its credit distribution business is expanding "rapidly" while its wealth distribution vertical is building traction through a diverse product portfolio, including fixed deposits (FDs), mutual funds (MFs), Systematic Investment Plans (SIPs), Digital Gold and Commenting on the development, MobiKwik's Co-founder, MD & CEO Bipin Preet Singh said that the license will strategically position MobiKwik to accelerate growth in its wealth distribution vertical and broaden its offerings throughout the capital markets ecosystem. This will reinforce its transformation into a comprehensive fintech platform, he added. This marks MobiKwik Group's second certificate during the current quarter. Earlier in April, Zaak ePayment Services Private Limited (Zaakpay) received a Certificate of Authorisation from the Reserve Bank of India (RBI) to operate as an Online Payment Aggregator. ETMarkets WhatsApp channel )
Economic Times
2 days ago
- Business
- Economic Times
Rs 9,300 crore stake! NSE IPO to unlock massive value for billionaire Radhakishan Damani
Radhakishan Damani, a prominent investor, is poised to benefit significantly from his 1.58% stake in the National Stock Exchange (NSE) as it approaches its IPO. Ace investor Radhakishan Damani is set to benefit from his investment in the National Stock Exchange. He holds a significant stake in NSE. The exchange is preparing for its IPO. Damani's investment could substantially increase his net worth. The IPO is expected in FY26. It will attract considerable investor interest. The listing could unlock value from his long-term investment. Tired of too many ads? Remove Ads A Rare Play in Financial Infrastructure Tired of too many ads? Remove Ads IPO Catalyst on the Horizon Ace investor Radhakishan Shivkishan Damani , often hailed as one of India's sharpest market minds, stands to gain substantially from his strategic stake in the National Stock Exchange NSE ), which is inching closer to its long-awaited IPO. According to shareholding filed, Damani holds a 1.58% stake in NSE, amounting to 3.91 crore shares. At the latest unlisted market price of Rs 2,389 per share, his stake is valued at a staggering Rs 9,300 crore. It's important to highlight that it is still unclear whether Damani intends to sell any part of his stake in the forthcoming makes NSE his second-largest holding by value—right after Avenue Supermarts (DMart), the retail giant he founded. It places well ahead of other key positions in his portfolio, including Trent (Rs 2,788 crore) and VST Industries (Rs 1,560 crore), underscoring the sheer scale and significance of this financial infrastructure play in his investment investment could add substantial momentum to Damani's net worth as NSE prepares for a long-awaited listing — expected sometime in FY26, following SEBI 's green light for DRHP filing, potentially by July Damani's portfolio is best known for high-conviction bets in the retail sector — most notably his Rs 1.92 lakh crore stake in Avenue Supermarts (DMart) — his quiet bet on NSE reflects a broader investment strategy that includes high-value, low-noise assets in India's financial a portfolio valued at over Rs 1.99 lakh crore across 12 publicly disclosed companies (as of March 2025), Damani's stake in NSE stands out as potentially one of the most rewarding in the near NSE's IPO is expected to attract massive investor interest, given its strong financials, market dominance, and monopoly status in the cash equities segment. For Damani, the listing could unlock considerable value from a long-term, pre-IPO investment that has now come full the exchange resolves its regulatory hurdles — including legacy co-location and dark fiber issues — the IPO timeline is taking shape. Post SEBI's no-objection certificate, the filing of the Draft Red Herring Prospectus (DRHP) and subsequent approval process is expected to stretch into late 2025, with a potential listing in Q4 FY26.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Mint
29-05-2025
- Business
- Mint
Stocks to buy: Expert Raja Venkatraman's recommendations for 29 May
Indian benchmark indices extended losses for a second consecutive session on Wednesday, weighed down by declines in heavyweights like ITC. The Nifty 50 slipped 63 points, or 0.3%, to close at 24,752, while the Sensex shed 240 points, or 0.29%, ending at 81,312. Broader markets, however, outperformed, with the Nifty Smallcap 100 rising 0.33% and the Nifty Midcap 100 ending largely unchanged. Here are two stocks from the mid and small cap space that can be tracked for the next three months: Astra Microwave Ltd (Current market price : ₹1163.70) Astra Microwave Products has delivered a solid financial performance in Q4FY25, showcasing strong growth in the aerospace and defence sector. The last reported numbers indicated that the revenue has now moved to ₹407.85 crore, reflecting a 15.23% year-over-year increase. Astra Microwave maintained an operating margin of 26.60%, demonstrating profitability despite market competition. On a quarter-on-quarter basis, revenue spiked by 57.75%, increasing from ₹258.54 crore in Q3 FY25 to ₹407.85 crore in Q4. Similarly, net income rose 54.94% QoQ, reinforcing financial strength. Another interesting newsflow is that Radhakishan Damani, a well-known investor, has returned to the company, participating in this fundraise, which further highlights the growing appeal of Astra Microwave's market prospects. In addition to financial instruments, Astra Microwave has undergone leadership and board changes, introduced new strategic perspectives while adjusting to evolving industry dynamics. The stock after a sterling performance till May 2024 faced a huge selloff much ahead of the market exhaustion and the profit booking that ensued resulted had undergone a painful scenario in the last set of weeks indicating that the time is challenging. However, the strong decline had erased 50% of the rise seen since March 2023 to some strong set of supports around 600. Around this level, the prices encountered some steady buying interest that held back the decline, push the prices higher. The strong and steady rise that we witnessed backed by buoyant financials and robust participation helped the prices surge higher. Eventually the rise managed to create a fresh new high and the robust participation is indicating a buying opportunity at current and on declines. Currently the strong surge seen in the prices has resulted in the prices doubling from the March lows highlighting the strong recovery seen in this counter. The quick turnaround in the trend of Astra Microwave's share price, signaling strong investor confidence and optimism about future prospects. As we look into the future, Astra Microwave's focus on financial discipline, operational efficiency, and strategic investments will play a crucial role in shaping its future growth trajectory and establishing itself as a leading player in the defence industry. With increasing revenue, profitability improvements, investor confidence, and corporate initiatives, Astra Microwave is positioned for sustained expansion. Considering the current scenario, one should consider buying at current levels and on dips near ₹1070 with a stop below ₹1045 for a rise to ₹ Read: NTPC's project execution delays remain its Achilles heel Glaxo Smithkline Pharma (Current market price: ₹3348.20) GSK, is a global healthcare company specializing in pharmaceuticals, vaccines, and consumer healthcare products. It is one of the world's largest research-based pharmaceutical companies, focused on discovering, developing, manufacturing, and marketing human health products. GlaxoSmithKline has a long history, with its origins in India dating back to 1924. In the last reported numbers of Q4 FY25 GlaxoSmithKline Pharmaceuticals Ltd. (GSK) has demonstrated strong financial performance in, reinforcing its position in the pharmaceutical sector. The company reported a 35% increase in net profit, reaching ₹263 crore, compared to ₹194.48 crore in the same quarter last year. Revenue from operations rose to ₹974.37 crore, reflecting steady growth. GSK's full-year revenue stood at ₹3,723 crore, marking a 9% increase, while profit after tax before exceptional items surged 32% to ₹915 crore. The company also announced a final dividend of ₹42 per equity share, highlighting its commitment to shareholder returns. After a volatile upward trajectory since October 2023 the ride lower from July 2024 was a scary one as the fast-paced decline had no respite and combined with the bearish market forces the trends capitulated. However, since the beginning of 2025 the situation began to improve and the prices also factored the volatility surrounding the Trump Tariff showdown. As things began to clear regarding his stance on Pharma and the implementation of the tariff the resistances began to give away. As seen on the higher timeframe charts , Glaxo demonstrated long body candles highlighting the robust participation. With the momentum too favouring some potential upside the tailwinds in this counter could carry the prices higher. The prices have been witnessing rampant volatility and the swift recovery is definitely a signature of more upside in store. Looking ahead, GSK remains committed to sustained above-market growth, with a focus on innovation and strategic expansion. The company's 100th Annual General Meeting is scheduled for June 27, 2025, where further strategic decisions are expected. With strong financial results, new product launches, and positive investor sentiment, GSK is well-positioned for continued success in the pharmaceutical industry. With robust volumes building up one can consider buying dips near ₹3180, stop ₹3100 target ₹3480-3650. Also Read: LIC's growth perils curb stock's valuation The methodologies and considerations utilised while selecting the candidates. 1. Blending Fundamentals with Technicals: While he emphasizes the importance of technical analysis, Dr. Narayan also acknowledges the role of fundamental analysis in understanding market trends and stock potential. 2. Price Action and Market Psychology: He focuses on price action as a key indicator of market sentiment. By studying price movements, he deciphers the psychology of market participants to predict future trends. 3. Risk Management: A cornerstone of his approach is managing risk effectively. He advocates for the use of stop-loss orders and actively uses Technical Analysis to manage his position sizing to protect capital. Also Read: This luggage leader is staging a turnaround. But can it overcome its baggage? Raja Venkatraman is co-founder, NeoTrader. His Sebi-registered research analyst registration no. is INH000016223. Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantees performance of the intermediary or provide any assurance of returns to investors. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.
